Viron Therapeutics Inc.
Records under this name other than patents Viron Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Viron Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,745,396 | Use of SERP-1 as an antiplatelet agent Lapsed on the fee record Ended Jun 29, 2022 · USPTO record | Lapsed on the fee record | Ended Jun 29, 2022 | USPTO record |
| US 6,894,155 | Nucleic Acid Molecules and Polypeptides for Immune Modulation Term ended Term ended Dec 10, 2021 · High confidence | Term ended | Term ended Dec 10, 2021 | High confidence |
| US 7,585,507 | Nucleic acid molecules and polypeptides for immune modulation Lapsed on the fee record Ended Sep 8, 2021 · USPTO record | Lapsed on the fee record | Ended Sep 8, 2021 | USPTO record |
| US 7,514,405 | Methods for Treating Transplant Rejection Lapsed on the fee record Ended Apr 7, 2021 · Medium confidence | Lapsed on the fee record | Ended Apr 7, 2021 | Medium confidence |
| US 8,268,331 | Nucleic acid molecules and polypeptides for immune modulation Lapsed on the fee record Ended Sep 18, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 18, 2020 | USPTO record |
| US 7,419,670 | Method of Treating Arthritis with SERP-1 and an Immunosuppressant Lapsed on the fee record Ended Sep 2, 2020 · High confidence | Lapsed on the fee record | Ended Sep 2, 2020 | High confidence |
| US 8,227,569 | Immunomodulatory protein and useful embodiments thereof Lapsed on the fee record Ended Jul 24, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 24, 2020 | USPTO record |
| US 7,285,530 | Use of SERP-1 as an antiplatelet agent Lapsed on the fee record Ended Oct 23, 2019 · USPTO record | Lapsed on the fee record | Ended Oct 23, 2019 | USPTO record |
| US 7,906,483 | Method for treating transplant rejection Lapsed on the fee record Ended Mar 15, 2019 · USPTO record | Lapsed on the fee record | Ended Mar 15, 2019 | USPTO record |
| US 6,495,515 | Chemokine binding protein and methods of use therefor Lapsed on the fee record Ended Dec 17, 2014 · USPTO record | Lapsed on the fee record | Ended Dec 17, 2014 | USPTO record |